arrow
S

Sarah T. Diepstraten

the walter and eliza hall institute of medical research
H指数:13
被引数:1,329

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A high-density CRISPR activation platform for mapping cancer dependencies and resistance pathways ex vivo and in vivo

高密度CRISPR激活平台用于体外和体内绘制癌症依赖性和耐药通路

2026-09-180
OA
Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma

全基因组活体内CRISPR筛选鉴定GATOR1复合物为Myc驱动的淋巴瘤的肿瘤抑制因子

2025-08-210
OAAI
Advancing the genetic engineering toolbox by combining AsCas12a knock-in mice with ultra-compact screening

通过结合AsCas12a基因敲入小鼠与超紧凑型筛选技术,推进基因工程工具箱的发展。

2025-01-300
OA
Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
2023-10-2422
OAAI
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells (Feb,10.1038/s41418-023-01122-3, 2023)
2023-02-240
OAAI
Generation of a CRISPR activationmouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance (vol 13, 4739, 2022)
2022-08-250
OAAI
Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance
2022-08-1214
OAAI